Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in Australia.
- DOI
- 10.1136/bmjopen-2022-069441
- Published
- 2023 Nov 29
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2022-069441,
title = {Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in Australia.},
author = {Mordaunt DA and Stark Z and Santos Gonzalez F and Dalziel K and Goranitis I},
year = {2023},
journal = {BMJ open},
doi = {10.1136/bmjopen-2022-069441},
url = {https://doi.org/10.1136/bmjopen-2022-069441}
}RIS
TY - JOUR TI - Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in Australia. AU - Mordaunt DA AU - Stark Z AU - Santos Gonzalez F AU - Dalziel K AU - Goranitis I PY - 2023 JO - BMJ open DO - 10.1136/bmjopen-2022-069441 UR - https://doi.org/10.1136/bmjopen-2022-069441 ER -
APA
DA, M., Z, S., F, S. G., K, D., & I, G. (2023). Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in Australia.. BMJ open. https://doi.org/10.1136/bmjopen-2022-069441
Source records
- pubmed · retrieved 2026-09-26T05:22:08.891Z